Douglas J. Swirsky - 14 Sep 2021 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Director
Signature
/s/ Christina Blakley, attorney-in-fact for Douglas J. Swirsky
Issuer symbol
CLRB
Transactions as of
14 Sep 2021
Net transactions value
+$26,000
Form type
4
Filing time
14 Sep 2021, 16:00:56 UTC
Previous filing
02 Jul 2021
Next filing
01 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLRB Common Stock Purchase $26,000 +25,000 $1.04 25,000 14 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.